MedPath

Marilyn Glassberg

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild Asthma

Phase 1
Terminated
Conditions
Asthma
First Posted Date
2017-05-02
Last Posted Date
2020-05-21
Lead Sponsor
Marilyn Glassberg
Target Recruit Count
3
Registration Number
NCT03137199
Locations
🇺🇸

University of Miami Miller School of Medicine, Miami, Florida, United States

Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis Bronchiectasis

Phase 1
Completed
Conditions
Bronchiectasis
First Posted Date
2015-12-09
Last Posted Date
2019-08-28
Lead Sponsor
Marilyn Glassberg
Target Recruit Count
6
Registration Number
NCT02625246
Locations
🇺🇸

University of Miami Hospitals & Clinics, Miami, Florida, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.